If a patient receives a continuous glucose monitor device through their medical benefit, they may be more adherent and may ...

Let's not forget about Abbott Laboratories' impressive streak of 52 consecutive annual dividend increases, which also makes ...

Eversense 365 is a fully-implantable CGM with a 365-day sensor, making it the first 1-year CGM option for diabetes management ...

NEW YORK — Glucose tracking is the future, Dexcom executives gushed at a glitzy launch event for their new, over-the-counter continuous glucose monitor ... The devices, which measure blood ...

Senseonics (NYSE:SENS) is set to bring the longest-lasting continuous glucose monitor (CGM) to market following a major ...

Continuous glucose monitors are small devices that automatically ... who don’t have diabetes, too. “Continuous glucose monitoring might be the best tool we have for precision nutrition ...

addressing one of the major drawbacks of existing CGM devices, deemed invasive due to the requirement of a needle inserted under the skin, which can cause discomfort. Additionally, a viscoelastic ...

As previously announced, Trinity Biotech has entered into a non-binding Letter of Intent with Bayer for the launch of a CGM device in China and India. As part of this, Trinity Biotech is launching ...

CGM devices use a small filament inserted under ... familiar with how to access their patients’ CGM data and how to best interpret the data and standard reports, such as the Ambulatory Glucose ...

And while another company could create a better CGM device, DexCom has proven incredibly ... just identified what they believe are the 10 best stocks for investors to buy now… and DexCom wasn ...

These devices are increasingly popular in diabetes management and health monitoring. As previously announced, Trinity Biotech has entered into a non-binding Letter of Intent with Bayer for the launch ...